Peripheral	JJ	peripheral JJ PennPOS
depletion	NN	depletion NN PennPOS
of	IN	of pp-f NUPOS
NK	NN	NK NN PennPOS
cells	NNS	cell NNS PennPOS
and	CC	and cc NUPOS
imbalance	NN	imbalance NN PennPOS
of	IN	of pp-f NUPOS
the	DT	the dt NUPOS
Treg/Th17	NN	Treg/Th17 NN PennPOS
axis	NN	axis NN PennPOS
in	IN	in IN PennPOS
idiopathic	JJ	idiopathic JJ PennPOS
pulmonary	JJ	pulmonary JJ PennPOS
fibrosis	NN	fibrosis NN PennPOS
patients	NNS	patient NNS PennPOS
.	.	. . NUPOS

The	DT	the dt NUPOS
immune	JJ	immune JJ PennPOS
response	NN	response NN PennPOS
plays	VBZ	play VBZ PennPOS
an	DT	a dt NUPOS
unsettled	JJ	unsettled JJ PennPOS
role	NN	role NN PennPOS
in	IN	in IN PennPOS
the	DT	the dt NUPOS
pathogenesis	NN	pathogenesis NN PennPOS
of	IN	of pp-f NUPOS
idiopathic	JJ	idiopathic JJ PennPOS
pulmonary	JJ	pulmonary JJ PennPOS
fibrosis	NN	fibrosis NN PennPOS
(	(	( ( NUPOS
IPF	NN	IPF NN PennPOS
)	)	) ) NUPOS
,	,	, , NUPOS
the	DT	the dt NUPOS
contribution	NN	contribution NN PennPOS
of	IN	of pp-f NUPOS
inflammation	NN	inflammation NN PennPOS
being	VBG	be vbg NUPOS
controversial	JJ	controversial JJ PennPOS
as	RB	as a-acp NUPOS
well	RB	well av NUPOS
.	.	. . NUPOS

Emerging	VBG	emerge VBG PennPOS
novel	JJ	novel JJ PennPOS
T	NN	T NN PennPOS
cell	NN	cell NN PennPOS
sub-populations	NNS	sub-population NNS PennPOS
including	VBG	include VBG PennPOS
regulatory	JJ	regulatory JJ PennPOS
T	NN	T NN PennPOS
lymphocytes	NNS	lymphocyte NNS PennPOS
(	(	( ( NUPOS
Treg	NNP	Treg NNP PennPOS
)	)	) ) NUPOS
and	CC	and cc NUPOS
interleukin	NN	interleukin NN PennPOS
(	(	( ( NUPOS
IL	NN	IL NN PennPOS
)	)	) ) NUPOS
-17	CD	-17 CD PennPOS
secreting	VBG	secrete VBG PennPOS
T	NN	T NN PennPOS
helper	NN	helper NN PennPOS
cells	NNS	cell NNS PennPOS
(	(	( ( NUPOS
Th17	NN	Th17 NN PennPOS
)	)	) ) NUPOS
may	MD	may vmb NUPOS
exert	VB	exert VBP PennPOS
antithetical	JJ	antithetical JJ PennPOS
actions	NNS	action NNS PennPOS
in	IN	in IN PennPOS
this	DT	this d NUPOS
scenario	NN	scenario NN PennPOS
.	.	. . NUPOS

Phenotype	NN	phenotype NN PennPOS
and	CC	and cc NUPOS
frequency	NN	frequency NN PennPOS
of	IN	of pp-f NUPOS
circulating	VBG	circulate VBG PennPOS
immune	JJ	immune JJ PennPOS
cell	NN	cell NN PennPOS
subsets	NNS	subset NNS PennPOS
were	VBD	be vbd NUPOS
assessed	VBN	assess VBN PennPOS
by	IN	by IN PennPOS
multi-parametric	JJ	multi-parametric JJ PennPOS
flow	NN	flow NN PennPOS
cytometry	NN	cytometry NN PennPOS
in	IN	in IN PennPOS
29	CD	29 CD PennPOS
clinically	RB	clinical RB PennPOS
stable	JJ	stable JJ PennPOS
IPF	NN	IPF NN PennPOS
patients	NNS	patient NNS PennPOS
and	CC	and cc NUPOS
17	CD	17 CD PennPOS
healthy	JJ	healthy JJ PennPOS
controls	NNS	control NNS PennPOS
.	.	. . NUPOS

The	DT	the dt NUPOS
interplay	NN	interplay NN PennPOS
between	IN	between IN PennPOS
Treg	NNP	Treg NNP PennPOS
lymphocytes	NNS	lymphocyte NNS PennPOS
expressing	VBG	express VBG PennPOS
transforming	VBG	transform VBG PennPOS
growth	NN	growth NN PennPOS
factor	NN	factor NN PennPOS
(	(	( ( NUPOS
TGF	NN	tgf NN PennPOS
)	)	) ) NUPOS
-	:	- : NUPOS
b	NN	b NN PennPOS
and	CC	and cc NUPOS
Th17	NN	Th17 NN PennPOS
cells	NNS	cell NNS PennPOS
was	VBD	be vbd NUPOS
also	RB	also av NUPOS
investigated	VBN	investigate VBN PennPOS
.	.	. . NUPOS

Proportion	NN	proportion NN PennPOS
and	CC	and cc NUPOS
absolute	JJ	absolute JJ PennPOS
number	NN	number NN PennPOS
of	IN	of pp-f NUPOS
natural	JJ	natural JJ PennPOS
killer	NN	killer NN PennPOS
(	(	( ( NUPOS
NK	NN	NK NN PennPOS
)	)	) ) NUPOS
cells	NNS	cell NNS PennPOS
were	VBD	be vbd NUPOS
significantly	RB	significant av-j NUPOS
reduced	VBN	reduce VBN PennPOS
in	IN	in IN PennPOS
IPF	NN	IPF NN PennPOS
patients	NNS	patient NNS PennPOS
in	IN	in IN PennPOS
comparison	NN	comparison NN PennPOS
with	IN	with pp NUPOS
controls	NNS	control NNS PennPOS
(	(	( ( NUPOS
p	NN	p NN PennPOS
<	JJR	< JJR PennPOS
0.001	CD	0.001 CD PennPOS
)	)	) ) NUPOS
.	.	. . NUPOS

Conversely	RB	converse RB PennPOS
,	,	, , NUPOS
the	DT	the dt NUPOS
proportion	NN	proportion NN PennPOS
and	CC	and cc NUPOS
absolute	JJ	absolute JJ PennPOS
number	NN	number NN PennPOS
of	IN	of pp-f NUPOS
CD3	NN	CD3 NN PennPOS
(	(	( ( NUPOS
+	CC	+ CC PennPOS
)	)	) ) NUPOS
CD4	NN	CD4 NN PennPOS
(	(	( ( NUPOS
+	CC	+ CC PennPOS
)	)	) ) NUPOS
CD25	NN	CD25 NN PennPOS
(	(	( ( NUPOS
high	JJ	high JJ PennPOS
)	)	) ) NUPOS
Foxp-3	NN	Foxp-3 NN PennPOS
(	(	( ( NUPOS
+	CC	+ CC PennPOS
)	)	) ) NUPOS
cells	NNS	cell NNS PennPOS
were	VBD	be vbd NUPOS
significantly	RB	significant av-j NUPOS
increased	VBN	increase VBN PennPOS
in	IN	in IN PennPOS
IPF	NN	IPF NN PennPOS
patients	NNS	patient NNS PennPOS
(	(	( ( NUPOS
p	NN	p NN PennPOS
=	JJ	= JJ PennPOS
0.000	CD	0.000 CD PennPOS
)	)	) ) NUPOS
.	.	. . NUPOS

As	IN	as c-acp NUPOS
in	IN	in IN PennPOS
controls	NNS	control NNS PennPOS
,	,	, , NUPOS
almost	RB	almost av NUPOS
the	DT	the dt NUPOS
totality	NN	totality NN PennPOS
of	IN	of pp-f NUPOS
cells	NNS	cell NNS PennPOS
(	(	( ( NUPOS
>	JJR	> JJR PennPOS
90	CD	90 crd NUPOS
%	NN	% NN PennPOS
)	)	) ) NUPOS
expressed	VBD	express VBD PennPOS
TGF-b	NN	TGF-b NN PennPOS
upon	IN	upon IN PennPOS
stimulation	NN	stimulation NN PennPOS
.	.	. . NUPOS

Interestingly	RB	interesting RB PennPOS
,	,	, , NUPOS
the	DT	the dt NUPOS
frequency	NN	frequency NN PennPOS
of	IN	of pp-f NUPOS
Th17	NN	Th17 NN PennPOS
cells	NNS	cell NNS PennPOS
was	VBD	be vbd NUPOS
significantly	RB	significant av-j NUPOS
compromised	VBN	compromise VBN PennPOS
in	IN	in IN PennPOS
IPF	NN	IPF NN PennPOS
patients	NNS	patient NNS PennPOS
(	(	( ( NUPOS
p	NN	p NN PennPOS
=	JJ	= JJ PennPOS
0.000	CD	0.000 CD PennPOS
)	)	) ) NUPOS
leading	VBG	lead VBG PennPOS
to	TO	to p-acp NUPOS
an	DT	a dt NUPOS
increased	VBN	increase VBN PennPOS
TGF-b/IL	NN	TGF-b/IL NN PennPOS
-17	CD	-17 CD PennPOS
ratio	NN	ratio NN PennPOS
(	(	( ( NUPOS
4.2	CD	4.2 CD PennPOS
2.3	CD	2.3 CD PennPOS
vs	CC	vs CC PennPOS
0.5	CD	0.5 CD PennPOS
0.3	CD	0.3 CD PennPOS
in	IN	in IN PennPOS
controls	NNS	control NNS PennPOS
,	,	, , NUPOS
p	NN	p NN PennPOS
=	JJ	= JJ PennPOS
0.000	CD	0.000 CD PennPOS
)	)	) ) NUPOS
.	.	. . NUPOS

Depletion	NN	depletion NN PennPOS
of	IN	of pp-f NUPOS
NK	NN	NK NN PennPOS
and	CC	and cc NUPOS
Th17	NN	Th17 NN PennPOS
cells	NNS	cell NNS PennPOS
along	IN	along IN PennPOS
with	IN	with pp NUPOS
a	DT	a dt NUPOS
not	RB	not xx NUPOS
compromised	VBN	compromise VBN PennPOS
Treg	NNP	Treg NNP PennPOS
compartment	NN	compartment NN PennPOS
delineate	VB	delineate VBP PennPOS
the	DT	the dt NUPOS
existence	NN	existence NN PennPOS
of	IN	of pp-f NUPOS
an	DT	a dt NUPOS
``	``	`` `` NONE
immune	JJ	immune JJ PennPOS
profile	NN	profile NN PennPOS
''	''	'' '' NONE
that	WDT	that WDT PennPOS
argue	VBP	argue VBP PennPOS
against	IN	against pp NUPOS
the	DT	the dt NUPOS
recent	JJ	recent JJ PennPOS
hypothesis	NN	hypothesis NN PennPOS
of	IN	of pp-f NUPOS
IPF	NN	IPF NN PennPOS
as	IN	as c-acp NUPOS
an	DT	a dt NUPOS
autoimmune	JJ	autoimmune JJ PennPOS
disease	NN	disease NN PennPOS
.	.	. . NUPOS

Our	PRP$	our po12 NUPOS
findings	NNS	finding n2 NUPOS
along	IN	along IN PennPOS
with	IN	with pp NUPOS
the	DT	the dt NUPOS
imbalance	NN	imbalance NN PennPOS
of	IN	of pp-f NUPOS
the	DT	the dt NUPOS
Treg/Th17	NN	Treg/Th17 NN PennPOS
axis	NN	axis NN PennPOS
more	RBR	much RBR PennPOS
closely	RB	close av-j NUPOS
suggest	VBP	suggest VBP PennPOS
these	DT	these d NUPOS
immune	JJ	immune JJ PennPOS
perturbations	NNS	perturbation NNS PennPOS
to	TO	to p-acp NUPOS
be	VB	be vbi NUPOS
similar	JJ	similar JJ PennPOS
to	TO	to p-acp NUPOS
those	DT	those d NUPOS
observed	VBN	observe VBN PennPOS
in	IN	in IN PennPOS
cancer	NN	cancer NN PennPOS
.	.	. . NUPOS

Clinical	JJ	clinical JJ PennPOS
relevance	NN	relevance NN PennPOS
,	,	, , NUPOS
limitations	NNS	limitation NNS PennPOS
and	CC	and cc NUPOS
perspectives	NNS	perspective NNS PennPOS
for	IN	for c-acp NUPOS
future	JJ	future JJ PennPOS
research	NN	research NN PennPOS
are	VBP	be vbb NUPOS
discussed	VBN	discuss VBN PennPOS
.	.	. . NUPOS

